Harmony Biosciences (NasdaqGM:HRMY) Q1 2026 Earnings call May 07, 2026 08:30 AM ET Company ParticipantsAdam Zaeske - Chief Commercial OfficerBrennan Doyle - Head of Investor RelationsGlenn Reicin - CFOJeffrey Dayno - President and CEOKumar Budur - Chief Medical and Scientific OfficerPeter Anastasiou - COOConference Call ParticipantsAmi Fadia - AnalystCorinne Johnson - AnalystDavid Amsellem - AnalystGregg Moskowitz - AnalystJason Gerberry - AnalystPatrick Trucchio - AnalystPete Stavropoulos - AnalystSoyoon S ...